Cmv seropositivity is a potential novel risk factor for severe covid-19 in non-geriatric patients

HIGHLIGHTS

• who: Simone Weber and colleagues from the University, UNITED STATES Munich, Germany, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany have published the Article: CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients, in the Journal: PLOS ONE of 21/01/2022
• what: Although the study shows surprising results that are possibly impactful for COVID-19 patients` outcomes, there are also some limitations that should be mentioned.

SUMMARY

In a prior study, the authors investigated the phenotype of SARS-CoV-2-specific . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.